Status | Study |
Available |
Study Name: 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia Condition: Congenital Hyperinsulinism Beckwith-Wiedemann Syndrome Date: 2013-07-30 Interventions: Drug: 18F-DOPA 18F-DOPA is a PET scan radiotracer. |
Available |
Study Name: Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism Condition: Conservatively Treated CHI Patients Date: 2013-03-24 |
Active, not recruiting |
Study Name: Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia Condition: Congenital Hyperinsulinism (CHI) Persiste Date: 2011-10-18 Interventions: Drug: 18 F-DOPA one time injection of 0.08 - 0.16 mCurie/kg of 18F-DOPA |
Recruiting |
Study Name: Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy Condition: Congenital Hyperinsulinism Date: 2010-02-17 Interventions: Drug: Lanreotide autogel The dose of Lan-ATG will be calculated according to the surface area of the pat |
Completed |
Study Name: Sandostatine® LP and Hyperinsulinism Condition: Congenital Hyperinsulinism Date: 2009-09-29 Interventions: Drug: Sandostatine LP Intramuscular injection of Sandostatine LP, once per month Dosage : 10 mg, 20 mg, |
Completed |
Study Name: Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity Condition: Congenital Hyperinsulinism Date: 2009-05-08 Interventions: Drug: Exendin-(9-39) 100-500pm |
Recruiting |
Study Name: Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia Condition: Congenital Hyperinsulinism Date: 2009-02-02 Interventions: Drug: exendin-(9-39) exendin-( |
Active, not recruiting |
Study Name: Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism Condition: Congenital Hyperinsulinism Hyperinsulinism Date: 2008-05-05 Interventions: Drug: F-DOPA 0.08-0.16 mCi/kg |
Completed |
Study Name: Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism Condition: Congenital Hyperinsulinism Date: 2007-12-10 Interventions: Drug: Exendin-(9-39) A short t |